Skip to main content
Top
Published in: European Journal of Nutrition 7/2011

01-10-2011 | Original Contribution

Plasma pharmacokinetics of catechin metabolite 4′-O-Me-EGC in healthy humans

Authors: Mathieu Renouf, Karine Redeuil, Karin Longet, Cynthia Marmet, Fabiola Dionisi, Martin Kussmann, Gary Williamson, Kornél Nagy

Published in: European Journal of Nutrition | Issue 7/2011

Login to get access

Abstract

Background

Tea is an infusion of the leaves of the Camellia sinensis plant and is the most widely consumed beverage in the world after water. Green tea contains significant amounts of polyphenol catechins and represents a promising dietary component to maintain health and well-being. Epidemiological studies indicate that polyphenol intake may have potential health benefits, such as, reducing the incidence of coronary heart disease, diabetes and cancer. While bioavailability of green tea bioactives is fairly well understood, some gaps still remain to be filled, especially the identification and quantification of conjugated metabolites in plasma, such as, sulphated, glucuronidated or methylated compounds.

Aim of the study

In the present study, we aimed to quantify the appearance of green tea catechins in plasma with particular emphasis on their methylated forms.

Results

After feeding 400 mL of green tea, 1.25% infusion to 9 healthy subjects, we found significant amounts of EC, EGC and EGCg in plasma as expected. EGC was the most bioavailable catechin, and its methylated form (4′-O-Me-EGC) was also present in quantifiable amounts. Its kinetics followed that of its parent compound. However, the relative amount of the methylated form of EGC was lower than that of the parent compound, an important aspect which, in the literature, has been controversial so far. The quantitative results presented in our study were confirmed by co-chromatography and accurate mass analysis of the respective standards. We show that the relative abundance of 4′-O-Me-EGC is ~40% compared to the parent EGC.

Conclusion

4′-O-Me-EGC is an important metabolite derived from catechin metabolism. Its presence in significant amounts should not be overlooked when assessing human bioavailability of green tea.
Footnotes
1
Bioavailability: in the present study, bioavailability is limited to plasma appearance of polyphenols over time.
 
Literature
1.
go back to reference Graham HN (1992) Green tea composition, consumption and polyphenol chemistry. Prev Med 21:334–350CrossRef Graham HN (1992) Green tea composition, consumption and polyphenol chemistry. Prev Med 21:334–350CrossRef
2.
go back to reference Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043CrossRef Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043CrossRef
3.
go back to reference Friedman M (2007) Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 51:116–134CrossRef Friedman M (2007) Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 51:116–134CrossRef
4.
go back to reference Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M, Tomita T (2000) Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem 11:216–222CrossRef Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M, Tomita T (2000) Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem 11:216–222CrossRef
5.
go back to reference Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26:373S–388S Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26:373S–388S
6.
go back to reference Thielecke F, Boschmann M (2009) The potential role of green tea catechins in the prevention of the metabolic syndrome—a review. Phytochemistry 70:11–24CrossRef Thielecke F, Boschmann M (2009) The potential role of green tea catechins in the prevention of the metabolic syndrome—a review. Phytochemistry 70:11–24CrossRef
7.
go back to reference Lee MJ, Wang ZY, Li H et al (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4:393–399 Lee MJ, Wang ZY, Li H et al (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4:393–399
8.
go back to reference Yang CS, Chen L, Lee MJ et al (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7:351–354 Yang CS, Chen L, Lee MJ et al (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7:351–354
9.
go back to reference Chow HHS, Cai Y, Alberts DS et al (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and Polyphenon E1. Cancer Epidemiol Biomarkers Prev 10:53–58 Chow HHS, Cai Y, Alberts DS et al (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and Polyphenon E1. Cancer Epidemiol Biomarkers Prev 10:53–58
10.
go back to reference Van Amelsvoort JMM, van Het Hof KH, Mathot JNJJ et al (2001) Plasma concentration of individual tea catechins after a single oral dose in humans. Xenobiotica 31:891–901CrossRef Van Amelsvoort JMM, van Het Hof KH, Mathot JNJJ et al (2001) Plasma concentration of individual tea catechins after a single oral dose in humans. Xenobiotica 31:891–901CrossRef
11.
go back to reference Lee MJ, Maliakal P, Chen L et al (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (−)-Epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11:1025–1032 Lee MJ, Maliakal P, Chen L et al (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (−)-Epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11:1025–1032
12.
go back to reference Chow HHS, Cai Y, Hakim IA et al (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin Cancer Res 9:3312–3319 Chow HHS, Cai Y, Hakim IA et al (2003) Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin Cancer Res 9:3312–3319
13.
go back to reference Henning SM, Niu Y, Lee NH et al (2004) Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80:1558–1564 Henning SM, Niu Y, Lee NH et al (2004) Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 80:1558–1564
14.
go back to reference Chow HHS, Hakim IA, Vining DR et al (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11:4627–4633CrossRef Chow HHS, Hakim IA, Vining DR et al (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11:4627–4633CrossRef
15.
go back to reference Henning SM, Niu Y, Liu Y et al (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16:610–616CrossRef Henning SM, Niu Y, Liu Y et al (2005) Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals. J Nutr Biochem 16:610–616CrossRef
16.
go back to reference Stalmach A, Troufflard S, Serafini M et al (2009) Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 53:S44–S53CrossRef Stalmach A, Troufflard S, Serafini M et al (2009) Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 53:S44–S53CrossRef
17.
go back to reference Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F (2010) Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition Article in press Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F (2010) Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition Article in press
18.
go back to reference Harada M, Kan Y, Naoki H, Fukui Y, Kageyama N, Nakai M, Miki W, Kiso Y (1999) Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (−)-epicatechin. Biosci Biotechnol Biochem 63:973–977CrossRef Harada M, Kan Y, Naoki H, Fukui Y, Kageyama N, Nakai M, Miki W, Kiso Y (1999) Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (−)-epicatechin. Biosci Biotechnol Biochem 63:973–977CrossRef
19.
go back to reference Walle T (2007) Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Mol Pharm 4:826–832CrossRef Walle T (2007) Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Mol Pharm 4:826–832CrossRef
20.
go back to reference Walle T (2009) Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. Int J Mol Sci 10:5002–5019CrossRef Walle T (2009) Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. Int J Mol Sci 10:5002–5019CrossRef
21.
go back to reference Wen X, Walle T (2006) Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36:387–397CrossRef Wen X, Walle T (2006) Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 36:387–397CrossRef
22.
go back to reference Wen X, Walle T (2006) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos 34:1786–1792CrossRef Wen X, Walle T (2006) Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos 34:1786–1792CrossRef
23.
go back to reference Mada-Yamamoto M, Inagaki N, Kitaura J, Chikumoto T, Kawahara H, Kawakami Y, Sano M, Miyase T, Tachibana H, Nagai H, Kawakami T (2004) O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol 172:4486–4492 Mada-Yamamoto M, Inagaki N, Kitaura J, Chikumoto T, Kawahara H, Kawakami Y, Sano M, Miyase T, Tachibana H, Nagai H, Kawakami T (2004) O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol 172:4486–4492
24.
go back to reference Mateos R, Goya L, Bravo L (2006) Uptake and metabolism of hydroxycinnamic acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as a model of the human liver. J Agric Food Chem 54 (23) 8724–8732 Mateos R, Goya L, Bravo L (2006) Uptake and metabolism of hydroxycinnamic acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as a model of the human liver. J Agric Food Chem 54 (23) 8724–8732
25.
go back to reference Baba S, Osakabe N, Natsume M, Yasuda A, Takizawa T, Nakamura T, Terao J (2000) Cocoa powder enhances the level of antioxidative activity in rat plasma. Br J Nutr 84:673–680 Baba S, Osakabe N, Natsume M, Yasuda A, Takizawa T, Nakamura T, Terao J (2000) Cocoa powder enhances the level of antioxidative activity in rat plasma. Br J Nutr 84:673–680
26.
go back to reference Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J (2001) In vivo comparison of the bioavailability of (+)-catechin, (−)-epicatechin and their mixture in orally administered rats. J Nutr 131:2885–2891 Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J (2001) In vivo comparison of the bioavailability of (+)-catechin, (−)-epicatechin and their mixture in orally administered rats. J Nutr 131:2885–2891
27.
go back to reference Miketova P, Schram KH, Whitney J, Li M, Huang R, Kerns E, Valcic S, Timmermann BN, Rourick R, Klohr S (2000) Tandem mass spectrometry studies of green tea catechins. Identification of three minor components in the polyphenolic extract of green tea. J Mass Spectrom 35:860–869CrossRef Miketova P, Schram KH, Whitney J, Li M, Huang R, Kerns E, Valcic S, Timmermann BN, Rourick R, Klohr S (2000) Tandem mass spectrometry studies of green tea catechins. Identification of three minor components in the polyphenolic extract of green tea. J Mass Spectrom 35:860–869CrossRef
28.
go back to reference Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11:1025–1032 Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11:1025–1032
29.
go back to reference Meng X, Lee MJ, Li C, Sheng S, Zhu N, Sang S, Ho CT, Yang CS (2001) Formation and identification of 4′-O-Methyl-(−)-epigallocatechin in humans. Drug Metab Disp 29:789–793 Meng X, Lee MJ, Li C, Sheng S, Zhu N, Sang S, Ho CT, Yang CS (2001) Formation and identification of 4′-O-Methyl-(−)-epigallocatechin in humans. Drug Metab Disp 29:789–793
30.
go back to reference Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, Yang CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol 15(8):1042–1050 Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, Yang CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem Res Toxicol 15(8):1042–1050
31.
go back to reference Renouf M, Guy P, Marmet C, Longet K, Fraering AL, Moulin J, Barron D, Dionisi F, Cavin C, Steiling H, Williamson G (2010) Plasma appearance and correlation between coffee and green tea metabolites in humans. Br J Nutr 9:1–6 Renouf M, Guy P, Marmet C, Longet K, Fraering AL, Moulin J, Barron D, Dionisi F, Cavin C, Steiling H, Williamson G (2010) Plasma appearance and correlation between coffee and green tea metabolites in humans. Br J Nutr 9:1–6
32.
go back to reference Kotani A, Miyashita N, Kusu F (2003) Determination of catechins in human plasma after commercial canned green tea ingestion by high-performance liquid chromatography with electrochemical detection using a microbore column. J Chromato B 788:269–275 Kotani A, Miyashita N, Kusu F (2003) Determination of catechins in human plasma after commercial canned green tea ingestion by high-performance liquid chromatography with electrochemical detection using a microbore column. J Chromato B 788:269–275
Metadata
Title
Plasma pharmacokinetics of catechin metabolite 4′-O-Me-EGC in healthy humans
Authors
Mathieu Renouf
Karine Redeuil
Karin Longet
Cynthia Marmet
Fabiola Dionisi
Martin Kussmann
Gary Williamson
Kornél Nagy
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 7/2011
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-010-0164-1

Other articles of this Issue 7/2011

European Journal of Nutrition 7/2011 Go to the issue